InvestorsHub Logo
Followers 22
Posts 3638
Boards Moderated 0
Alias Born 07/20/2006

Re: None

Wednesday, 06/29/2016 12:40:25 PM

Wednesday, June 29, 2016 12:40:25 PM

Post# of 58
Momenta, Sandoz allowed to broaden claims over quality test patent

A federal judge has allowed Momenta Pharmaceuticals and Sandoz Inc to broaden a lawsuit accusing Amphastar Pharmaceuticals of infringing a patent on quality control methods used in making the blood thinner enoxaparin, the generic form of French drug maker Sanofi's Lovenox.

U.S. District Judge Nathaniel Gorton in Massachusetts said Tuesday that Momenta and Sandoz could add new infringement allegations to their complaint in light of a ruling last November by the U.S. Court of Appeals for the Federal Circuit that California-based Amphastar is not protected by a safe harbor provision in the patent law.

http://www.reuters.com/article/health-patent-idUSL1N19F0C7

Ampha market cap is about 750 M and is valued way less than the damage they caused. Momenta was making about a 1 M a day on lovonox before the Ampha debacle. bp

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=123595244
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMPH News